<DOC>
	<DOC>NCT02562170</DOC>
	<brief_summary>Randomized controlled trial to look at early complications, cosmetic outcome, patient satisfaction and thickness of the tissue overlying the implant at the lower pole in immediate implant based breast reconstruction after Skin or Nipple Sparing Mastectomy with either a mesh (TiLOOP Bra) or an ADM (Protexa). Multicenter austrian trial with four breast cancer centers, 50 patients randomized 1:1 in the TiLoop or Protexa group.</brief_summary>
	<brief_title>Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Hereditary Breast and Ovarian Cancer Syndrome</mesh_term>
	<criteria>breast cancer patients with indication for skin or nipple sparing mastectomy BRCA1/2 mutation carriers with indication for skin or nipple sparing mastectomy prior local radiotherapy inflammatory breast cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>breast</keyword>
	<keyword>reconstruction</keyword>
	<keyword>mesh</keyword>
	<keyword>acellular dermal matrix</keyword>
</DOC>